Northwestern Medicine Rheumatology is pleased to welcome Carrie Richardson, MD. Dr. Richardson joins as assistant professor of Medicine and co-director of the Northwestern Medicine Scleroderma Program. She specializes in the treatment of scleroderma, and has a background in clinical and translational research in scleroderma.
Dr. Richardson earned her medical degree from Northwestern University Feinberg School of Medicine. She completed her residency in internal medicine at McGaw Medical Center of Northwestern University and a fellowship in rheumatology at Johns Hopkins University.
"As the co-director of the Scleroderma Program, my number one priority is to provide patients with great care," says Dr. Richardson. "That means treating patients with respect, listening to their concerns, and collaborating with our network of multidisciplinary scleroderma experts to develop the best treatment plan for each individual patient. Providing great care also means providing patients opportunities to participate in clinical trials that may lead to the next big breakthrough in scleroderma treatment. When our patients come to our center, I want them to leave feeling confident that they have access to the most knowledgeable care team and the most advanced therapies.
"It is also essential that, while providing great care for patients, we continue to lead the search for a cure for a scleroderma," she continues. "Our network of basic and translational science researchers continues to push the boundaries of our understanding of immunologic dysregulation in scleroderma in the hopes that we can develop effective therapies targeted precisely to each patient's specific disease stage and complications."
Read more about the Northwestern Medicine Scleroderma Program >
Carrie L. Richardson, MD, is co-director of the Scleroderma Program and assistant professor of Medicine in the Division of Rheumatology at Northwestern Medicine.
Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.